Home0656 • HKG
add
Fosun International Ltd
Nakaraang pagsara
$4.97
Sakop ng araw
$4.94 - $5.00
Sakop ng taon
$3.74 - $6.81
Market cap
40.59B HKD
Average na Volume
4.80M
P/E ratio
-
Dividend yield
0.40%
Primary exchange
HKG
Sa balita
TipRanks
16 oras ang nakalipas
Fosun Pharma Subsidiary Gains Approval for Innovative Cancer Drug Trial
0.11%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 43.64B | -10.79% |
Gastos sa pagpapatakbo | 12.02B | -7.18% |
Net na kita | 330.58M | -8.19% |
Net profit margin | 0.76 | 2.70% |
Kita sa bawat share | — | — |
EBITDA | 2.14B | 2.29% |
Aktuwal na % ng binabayarang buwis | 31.04% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 111.54B | -31.19% |
Kabuuang asset | 735.69B | -10.49% |
Kabuuang sagutin | 538.35B | -12.13% |
Kabuuang equity | 197.33B | — |
Natitirang share | 8.12B | — |
Presyo para makapag-book | 0.34 | — |
Return on assets | 0.09% | — |
Return on capital | 0.16% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 330.58M | -8.19% |
Cash mula sa mga operasyon | 7.30B | 37.16% |
Cash mula sa pag-invest | -25.72B | -2,082.96% |
Cash mula sa financing | -4.08B | -315.00% |
Net change in cash | -19.02B | -323.33% |
Malayang cash flow | -1.52B | 0.62% |
